Trial Profile
A study evaluating pharmacokinetics and pharmacodynamics of Elobixibat in Japanese patients with chronic constipation.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jul 2018
Price :
$35
*
At a glance
- Drugs Elobixibat (Primary)
- Indications Constipation
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 29 Jun 2018 Results assessing effect of single and multiple doses of elobixibat, on chronic constipation published in the British Journal of Clinical Pharmacology
- 28 Jul 2017 New trial record
- 27 Jun 2017 Results presented at the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics